Global HIV Self-Testing Kits Market 2023-2029
An HIV self-test (or rapid self-test) is an antibody test that can be used at home or in a private location. HIV self-testing is a screening test and requires self-testers with a reactive (preliminary positive) result to receive further testing from a trained provider using a validated national testing algorithm. The global HIV self-testing kits market was valued at USD 1,277 million in 2022 to USD 1,581 million by 2029, progressing at a CAGR of 3.1% from 2023 to 2029, according to Gen Consulting Company.
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global HIV self-testing kits market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the technology, sample type, distribution channel, and region. The global market for HIV self-testing kits can be segmented by technology: immunofiltration, lateral flow immunoassay (LFI). The LFI segment is estimated to account for the largest share of the global HIV self-testing kits market. HIV self-testing kits market is further segmented by sample type: blood sample, oral fluid (saliva) sample, urine sample. The blood sample segment held the largest revenue share in 2022. Based on distribution channel, the HIV self-testing kits market is segmented into: offline, online. Globally, the online segment made up the largest share of the HIV self-testing kits market. On the basis of region, the HIV self-testing kits market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America was the largest contributor to the global HIV self-testing kits market in 2022.
Market Segmentation
By technology: immunofiltration, lateral flow immunoassay (LFI)
By sample type: blood sample, oral fluid (saliva) sample, urine sample
By distribution channel: offline, online
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
The report has also analysed the competitive landscape of the global HIV self-testing kits market with some of the key players being Abbott Laboratories, AccuBioTech Co., Ltd., Atomo Diagnostics Limited, Beijing Jinhao Pharmaceutical Co., Ltd., Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., bioLytical Laboratories Inc., bioMerieux SA, Bio-Rad Laboratories, Inc., Biosynex SA, Chembio Diagnostics, Inc., Cupid Limited, Guangzhou Wondfo Biotech Co., Ltd., HUMAN Gesellschaft fur Biochemica und Diagnostica mbH, InTec PRODUCTS, INC., J.Mitra & Co. Pvt. Ltd., Medsource Ozone Biomedicals Private Limited, Meril Life Sciences Private Limited, MP Biomedicals, Inc, Nanjing Synthgene Medical Technology Co., Ltd., NewScen Coast Bio-Pharmaceutical Co., Ltd. (NewScen), OraSure Technologies Inc, Premier Medical Corporation Private Limited, Qingdao Hightop Biotech Co., Ltd., SD Biosensor, Inc., Shanghai Kehua Bio-Engineering Co., Ltd., Trinity Biotech Plc, Turklab A.S., Zhejiang Orient Gene Biotech Co., Ltd., Zhengzhou Antu Bio-Engineering Co., Ltd., Zhuhai Livzon Diagnostics Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Scope of the Report
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook